Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-04-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.902929/full |
| _version_ | 1818547155890077696 |
|---|---|
| author | Zvi Ram Chae-Yong Kim Andreas F. Hottinger Ahmed Idbaih Garth Nicholas Jay-Jiguang Zhu |
| author_facet | Zvi Ram Chae-Yong Kim Andreas F. Hottinger Ahmed Idbaih Garth Nicholas Jay-Jiguang Zhu |
| author_sort | Zvi Ram |
| collection | DOAJ |
| first_indexed | 2024-12-12T08:02:56Z |
| format | Article |
| id | doaj.art-3766c41d65664676962c68b54b95f75b |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-12T08:02:56Z |
| publishDate | 2022-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-3766c41d65664676962c68b54b95f75b2022-12-22T00:32:03ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-04-011210.3389/fonc.2022.902929902929Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical TrialZvi Ram0Chae-Yong Kim1Andreas F. Hottinger2Ahmed Idbaih3Garth Nicholas4Jay-Jiguang Zhu5Department of Neurosurgery, Tel Aviv Medical Center and Tel Aviv University School of Medicine, Tel Aviv, IsraelDepartment of Neurosurgery, Seoul National University College of Medicine, Seoul, South KoreaDepartment of Clinical Neuroscience, CHUV Lausanne University Hospital & University of Lausanne, Lausanne, SwitzerlandService de Neurologie 2-Mazarin, Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière—Charles Foix, Service de Neurologie 2-Mazarin, Paris, FranceDepartment of Medicine, University of Ottawa, Ottawa, ON, CanadaDepartment of Neurosurgery, University of Texas Health Science Center at Houston, Houston, TX, United Stateshttps://www.frontiersin.org/articles/10.3389/fonc.2022.902929/fullelderly patientsnewly diagnosed glioblastomaTTFieldsTumor Treating Fieldsphase 3 clinical trialefficacy and safety |
| spellingShingle | Zvi Ram Chae-Yong Kim Andreas F. Hottinger Ahmed Idbaih Garth Nicholas Jay-Jiguang Zhu Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial Frontiers in Oncology elderly patients newly diagnosed glioblastoma TTFields Tumor Treating Fields phase 3 clinical trial efficacy and safety |
| title | Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title_full | Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title_fullStr | Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title_full_unstemmed | Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title_short | Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial |
| title_sort | corrigendum efficacy and safety of tumor treating fields ttfields in elderly patients with newly diagnosed glioblastoma subgroup analysis of the phase 3 ef 14 clinical trial |
| topic | elderly patients newly diagnosed glioblastoma TTFields Tumor Treating Fields phase 3 clinical trial efficacy and safety |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.902929/full |
| work_keys_str_mv | AT zviram corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial AT chaeyongkim corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial AT andreasfhottinger corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial AT ahmedidbaih corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial AT garthnicholas corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial AT jayjiguangzhu corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial |